Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Innate and Adaptive Immunity in COPD Exacerbations: Prospective Cohort Study

NCT00281216 is registered in ClinicalTrials.gov with University of Michigan as lead sponsor.

NCT NCT00281216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00281216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Innate and Adaptive Immunity in COPD Exacerbations: Prospective Cohort Study
Lead sponsor
University of Michigan
Phase
Observational
Overall status
Completed
Start date
September 30, 2005
Completion date
September 30, 2010
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung diseases, lung diseases, obstructive, pulmonary disease, chronic obstructive